Hangzhou Tigermed Consulting Co., Ltd.(3347.H.K.)
Immunotech Biopharm Ltd(6978.H.K)
Click here to download the document.
Forwin Capital Management Limited (“Forwin Capital”) is a wholly-owned subsidiary of Forwin Holding Limited. Forwin Capital is a licensed corporations under the Hong Kong Securities and Futures Commission (“SFC”) approved to conduct Type 4 (advising on securities) and Type 9 (Provide asset management) regulated activities. Forwin Capital is dedicated to providing customers with the most updated investment information and market trends. Our professional team will from time to time deliver research reports with respect to China, Hong Kong or global stock markets. While monitoring international fund flow and tracking individual stocks, our team will also write thematic reports of different industries and provide IPO information so as to enabling our customers to better understand the market situation when making every important investment decision.